| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Baudax Bio, Inc. | Director | Common Stock | 42,534 | $108,360 | $2.55 | 15 Jun 2022 | Direct |
| Medicus Pharma Ltd. | Director | Stock Option (right to buy) | 25,000 | $74,750 | $2.99 | 16 Dec 2025 | Direct |
| Societal CDMO, Inc. | Director | Common Stock | 0 | $0 | $1.10 | 08 Apr 2024 | Direct |
| Medicus Pharma Ltd. | Director | Common Shares, no par value ("Common Shares") | 1,250 | 31 Dec 2024 | Direct | ||
| Societal CDMO, Inc. | Director | Stock Option (Right to Buy) | 0 | 08 Apr 2024 | Direct | ||
| SPECTRUM PHARMACEUTICALS INC | Director | Common Stock, $0.001 par value | 0 | $1.10 | 31 Jul 2023 | Direct | |
| SPECTRUM PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 0 | 31 Jul 2023 | Direct |